RTGN News Alert Ruthigen Inc. (RTGN) 3.83 12/13/2014 07:01:4

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ruthigen Inc. (RTGN) 3.83 $RTGN

Strong Portfolio, Dividends Make Merck An Attractive Opportunity
Kanak Kanti De - at Seeking Alpha - Mon Dec 08, 2:40PM CST

TTPH: 31.57 (-0.39), CBST: 96.31 (+0.04), MRK: 57.72 (-1.62), RTGN: 3.83 (-0.17)

Ruthigen EPS of -$0.35
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 3:46PM CST

RTGN: 3.83 (-0.17)

Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2015
GlobeNewswire - Thu Nov 13, 3:08PM CST
-- Total revenue of $3.3 million for the second quarter
OCLS: 1.64 (+0.16), RTGN: 3.83 (-0.17)

Ruthigen Reports Fiscal Second Quarter 2015 Financial Results
PR Newswire - Thu Nov 13, 3:01PM CST
Ruthigen, Inc. (NASDAQ: RTGN) today reported financial results for its fiscal second quarter 2015 ended September 30, 2014.
RTGN: 3.83 (-0.17)

Ruthigen To Hold Fiscal Second Quarter 2015 Financial Results Conference Call On Thursday, November 13, 2014
PR Newswire - Thu Nov 06, 6:00AM CST
Ruthigen, Inc., (NASDAQ: RTGN) today announced that the financial results for its fiscal second quarter 2015, ended September 30, 2014, will be released after the U.S. markets close on November 13, 2014. The earnings release will be followed by a conference call at 1:30 p.m. PDT (4:30 p.m. EDT) on November 13, 2014, to discuss fiscal second quarter 2015 results.
RTGN: 3.83 (-0.17)

Ruthigen Announces First Patient Enrollment in the Phase 1/2 Human Clinical Trial of RUT58-60, a Broad-Spectrum Anti-Infective Drug Candidate Designed for Prophylactic Use During Invasive Surgery
PR Newswire - Tue Nov 04, 6:00AM CST
Ruthigen, Inc. (NASDAQ: RTGN), announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
RTGN: 3.83 (-0.17)

Nasdaq stocks posting largest percentage increases
AP - Tue Oct 21, 12:44PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
EGLT: 6.26 (+0.19), XPLR: 6.30 (-0.10), ILMN: 184.30 (-2.53), SYNL: 17.40 (-0.27), QVCB: 28.88 (-0.39), CZR: 12.83 (-2.03), QVCA: 28.18 (-0.27), ORPN: 6.71 (-0.54), SHLD: 32.30 (+0.15), RTGN: 3.83 (-0.17)

Ruthigen Initiates Phase 1/2 Clinical Trial of RUT58-60
PR Newswire - Wed Oct 08, 6:00AM CDT
Ruthigen Inc. (NASDAQ: RTGN), a biopharmaceutical company focused on pioneering new therapies to improve patient outcomes and reduce healthcare costs associated with infections related to post-operative invasive procedures, announces the initiation of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
RTGN: 3.83 (-0.17)

IPO Value Surges To The Highest Level In More Than a Decade
ACCESSWIRE - Fri Sep 19, 11:52AM CDT
Deerfield Beach, FL / September 19, 2014 / As the U.S. economy continues to recover, deal making activity has surged. Indeed, both M&As and initial public offerings (IPO) have seen a surge this year. In fact data from Dealogic shows that companies raised $46.4 billion in the first eight months of 2014, the highest of any year since 2000. The value of IPOs will get a huge boost as Chinese e-commerce company Alibaba Group Holding Ltd. (NYSE: BABA) completed its IPO on Thursday.
RICE: 23.91 (+0.38), FB: 77.83 (+0.10), FOMX: 6.42 (+0.19), RSPP: 21.03 (-0.03), RTGN: 3.83 (-0.17), BABA: 105.11 (+0.14)

Ruthigen to Present at the Rodman & Renshaw 16th Annual Global Investment Conference in New York City
PR Newswire - Thu Sep 04, 6:00AM CDT
Ruthigen, Inc., (NASDAQ: RTGN) a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company is scheduled to present at the Rodman & Renshaw 16th Annual Global Investment Conference on Wednesday, September 10, 2014 at 2:30 p.m. ET. The conference will be held at the New York Palace Hotel in New York City.
RTGN: 3.83 (-0.17)

Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60
PR Newswire - Tue Aug 26, 6:00AM CDT
Ruthigen Inc. (NASDAQ: RTGN), a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee (DMC) to begin enrolling patients in the Company's planned Phase 1/2 clinical trial.
RTGN: 3.83 (-0.17)

Biotechnology Stocks to Keep an Eye On
ACCESSWIRE - Wed Aug 20, 8:01AM CDT
Deerfield Beach, FL / Aug 20, 2014 / It has been a disappointing year for biotechnology stocks so far after last year's surge. The correction was expected after last year's surge; however, the losses were accentuated after Fed Chair Janet Yellen's comments earlier this year regarding a possible bubble in biotech and social media stocks.
ACHN: 13.28 (-0.11), AVEO: 0.65 (-0.03), AEGR: 21.09 (-0.22), RTGN: 3.83 (-0.17)

Ruthigen Reports Fiscal First Quarter 2015 Financial Results
PR Newswire - Thu Aug 14, 3:17PM CDT
Ruthigen, Inc. (NASDAQ: RTGN) today reported financial results for its fiscal first quarter 2015 ended June 30, 2014.
RTGN: 3.83 (-0.17)

Ruthigen To Hold Fiscal First Quarter 2015 Financial Results Conference Call On Thursday, August 14, 2014
PR Newswire - Thu Aug 07, 3:45PM CDT
Ruthigen, Inc., (NASDAQ: RTGN) today announced that the financial results for its fiscal first quarter 2015, ended June 30, 2014, will be released after the U.S. markets close on August 14, 2014. The earnings release will be followed by a conference call at 1:30 p.m. PDT (4:30 p.m. EDT) on August 14, 2014, to discuss fiscal first quarter 2015 results.
RTGN: 3.83 (-0.17)

Oculus Innovative Sciences Reports Revenues of $3.4 Million and Net Loss of $70,000 for First Quarter of Fiscal 2015
GlobeNewswire - Thu Aug 07, 3:42PM CDT
-- Net loss of $70,000, reduced $1.6 million from same period last year
OCLS: 1.64 (+0.16), RTGN: 3.83 (-0.17)

Biotechnology Sector in Focus
ACCESSWIRE - Thu Jul 31, 8:01AM CDT
Deerfield Beach, FL / ACCESSWIRE / July 31, 2014 / One of the major concerns for big pharma is patent expirations. Patent expirations will result in a loss of $34 billion in revenue at big pharma companies this year. This was after pharma companies lost $55 billion and $28 billion in revenue in 2012 and 2013, respectively. In 2015, products worth $66 billion will see their patents expire.
TTPH: 31.57 (-0.39), SYN: 1.47 (-0.04), IMUC: 0.82 (-0.03), SIGA: 1.51 (-0.01), RTGN: 3.83 (-0.17)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ballard's Q3 2026: Navigating Losses and Bold Moves

Updated Category News Views 29

Ballard’s Financial Puzzles in Q3 2026 Riding the rough waters of the third quarter in 2026, Ballard Power Systems set out its stall with some eyebrow-raising numbers. This ain't the bustling diner vibe we normally see for a thriving business. The results paint a cautious picture sprinkled with strategic shifts that demand a keen eye. GeoPura Acquisition: A Strategic...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 97

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 181

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 385

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 74

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 41

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 112

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 67

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 635

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
AI Pushes Asset Managers Towards New Investment Growth

Updated Category News Views 5

AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...

Continue Reading

Top 5 Most Recently Viewed Articles

Movable Ink Boosts AI Marketing Strategies with Global Expansion

Updated Category News Views 165

Movable Ink Expands its AI Marketing Solutions Across Europe Movable Ink, a leader in AI-powered personalisation, has significantly boosted its presence in Europe. The company’s innovative approach, termed the Autonomous Marketing strategy, is proving to reshape the marketing landscape. Now, with the launch of its sophisticated Da Vinci product, Movable Ink is setting a...

Continue Reading
Crypto Market Update: Election Impact on Bitcoin and Ethereum

Updated Category News Views 110

Market Movements Amid Election Uncertainty In recent days, leading cryptocurrencies have experienced a noticeable pullback. The shifts in market sentiment appear closely linked to the political atmosphere, particularly surrounding presidential election predictions. As the likelihood of Donald Trump's election victory declined, key cryptocurrencies like Bitcoin and...

Continue Reading
Festi hf. Receives Non-Binding Offers for Olíudreifing ehf.

Updated Category News Views 101

Festi hf. Receives Non-Binding Offers for Olíudreifing ehf. Festi hf. has recently announced the progress concerning Olíudreifing ehf. which is a crucial infrastructure entity specializing in fuel storage and distribution in Iceland. After initiating the sales process on September 26, 2024, the company has now received non-binding offers for all outstanding shares in...

Continue Reading
Canadian Solar Plans US$200 Million Convertible Notes Offering

Updated Category News Views 141

Canadian Solar Announces Offering of Convertible Senior Notes Canadian Solar Inc. (NASDAQ: CSIQ) has recently disclosed plans for the proposed offering of US$200 million in convertible senior notes due 2031. This offering is contingent upon market conditions and other factors. The convertible notes are set to be offered and sold privately to qualified institutional...

Continue Reading
HPQ Silicon Achieves Milestone with First Battery Cell Shipments

Updated Category News Views 185

HPQ Silicon's Exciting Development in Battery Technology HPQ Silicon Inc. (“HPQ”) is thrilled to announce that it has successfully completed and shipped its first industrial batches of high-performance lithium-ion battery cells. Manufactured using their innovative GEN3 silicon-based anode material, these initial cells, which come in the 18650 and 21700 formats under...

Continue Reading